Login
Products
Login
Home
Alerts
Search
Watchlist
Products

GPT Healthcare Ltd

GPTHEALTH
NSE
135.50
1.87%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

GPT Healthcare Ltd

GPTHEALTH
NSE
135.50
1.87%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,112Cr
Close
Close Price
135.50
Industry
Industry
Hospitals
PE
Price To Earnings
27.43
PS
Price To Sales
2.48
Revenue
Revenue
448Cr
Rev Gr TTM
Revenue Growth TTM
10.48%
PAT Gr TTM
PAT Growth TTM
-18.68%
Peer Comparison
How does GPTHEALTH stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
GPTHEALTH
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
9696108979998106102101107119120
Growth YoY
Revenue Growth YoY%
16.63.93.51.7-2.15.82.09.512.517.6
Expenses
ExpensesCr
737783767680828181909699
Operating Profit
Operating ProfitCr
241925212318232121172321
OPM
OPM%
24.519.822.821.723.318.422.220.820.416.219.117.2
Other Income
Other IncomeCr
211122322211
Interest Expense
Interest ExpenseCr
322221111222
Depreciation
DepreciationCr
444555555677
PBT
PBTCr
191419161815211816111513
Tax
TaxCr
946565653343
PAT
PATCr
1010141113101512138119
Growth YoY
PAT Growth YoY%
30.137.423.8-0.29.86.80.6-22.9-28.5-23.5
NPM
NPM%
10.810.412.511.912.910.214.012.012.77.28.97.8
EPS
EPS
1.31.31.71.41.61.21.81.51.60.91.31.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
212243337361400407448
Growth
Revenue Growth%
14.639.07.010.81.79.9
Expenses
ExpensesCr
176194264287312324366
Operating Profit
Operating ProfitCr
36497474888382
OPM
OPM%
16.920.221.920.621.920.518.2
Other Income
Other IncomeCr
4656586
Interest Expense
Interest ExpenseCr
1414119737
Depreciation
DepreciationCr
11121415181925
PBT
PBTCr
15295456686955
Tax
TaxCr
481217201915
PAT
PATCr
11214239485041
Growth
PAT Growth%
92.597.5-6.422.54.5-18.8
NPM
NPM%
5.28.712.310.811.912.39.1
EPS
EPS
4.17.95.24.96.06.14.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
18188080828282
Reserves
ReservesCr
69767885136166172
Current Liabilities
Current LiabilitiesCr
65606882777485
Non Current Liabilities
Non Current LiabilitiesCr
11712397805062125
Total Liabilities
Total LiabilitiesCr
308317323327346384463
Current Assets
Current AssetsCr
63868681807987
Non Current Assets
Non Current AssetsCr
246231238245265305376
Total Assets
Total AssetsCr
308317323327346384463

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
414366666967
Investing Cash Flow
Investing Cash FlowCr
-54-16-55-25-33
Financing Cash Flow
Financing Cash FlowCr
12-22-57-73-49-35
Net Cash Flow
Net Cash FlowCr
-143-2-50
Free Cash Flow
Free Cash FlowCr
-53859585018
CFO To PAT
CFO To PAT%
378.4203.8158.4170.1144.0135.0
CFO To EBITDA
CFO To EBITDA%
115.887.889.489.378.380.9

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00001,4481,204
Price To Earnings
Price To Earnings
0.00.00.00.030.324.1
Price To Sales
Price To Sales
0.00.00.00.03.63.0
Price To Book
Price To Book
0.00.00.00.06.64.9
EV To EBITDA
EV To EBITDA
3.02.11.31.016.714.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
81.976.474.179.079.380.6
OPM
OPM%
16.920.221.920.621.920.5
NPM
NPM%
5.28.712.310.811.912.3
ROCE
ROCE%
15.021.225.126.330.225.7
ROE
ROE%
12.622.526.323.621.920.1
ROA
ROA%
3.56.712.911.913.813.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** **GPT Healthcare Limited**, operating under the **ILS Hospitals** brand, is a well-established corporate healthcare provider focused exclusively on Eastern India. Founded in July 2000 in Salt Lake, Kolkata, the company has grown into a trusted network of mid-sized, community-centric tertiary care hospitals. Listed on the BSE and NSE (symbol: GPTHEALTH), GPT Healthcare combines clinical excellence, operational efficiency, and technology-driven care to serve the rising demand for quality healthcare in underpenetrated urban markets. --- ### **Current Network & Capacity (as of Nov 2025)** The company operates **five multi-specialty hospitals** with a total of **719 beds** across West Bengal, Tripura, and Chhattisgarh: | Location | Beds | Key Features | |---------------|------|-------------| | **Salt Lake** (Kolkata) | 85 | Robotic surgery excellence, 700+ robotic procedures, ARPOB: ₹41,062, Occupancy: 62% | | **Dum Dum** (Kolkata) | 155 | Highest ARPOB (₹41,183–₹42,684), 69–78% occupancy, renal transplants, EBITDA breakeven in 10 months | | **Howrah** (Kolkata) | 116 | ARPOB: ₹34,900–₹35,600, robotic knee surgeries (34 performed), rapid EBITDA breakeven (8 months), 45–58% occupancy | | **Agartala** (Tripura) | 205 | Largest corporate hospital in Tripura, NABH/NABL accredited, radiation oncology launched, 70%+ target occupancy | | **Raipur** (Chhattisgarh) | 158 | Commissioned Apr 2025; ARPOB ~₹40,000, 7–10% occupancy (ramping up), EBITDA breakeven expected in 12–15 months | --- ### **Financial & Operational Highlights (H1 FY26)** - **Total Income**: ₹228.92 crore - **EBITDA Margin**: 18.79% (vs. 22.1% in FY25) - **Average Revenue Per Occupied Bed (ARPOB)**: ₹38,376 (up from ₹37,180 in FY25) - **Average Length of Stay (ALOS)**: 3.49 days (vs. 3.54 days in FY25) - **Bed Occupancy**: 44.7% (impacted by new Raipur launch) - **ROCE**: 11.7% | **ROE**: 7.4% - **Dividend Declared**: ₹1 per share - **Revenue Source**: 94–96% from cash and insurance (strong cash conversion) - **CFO-to-EBITDA**: ~80% (industry-leading) --- ### **Clinical Excellence & Service Expansion** - **Robotic Surgery**: Over **700 robotic surgeries** completed across Salt Lake and Howrah (focus on orthopedics, bariatrics, general surgery). Howrah has performed **34 robotic knee surgeries**. - **Renal Transplants**: Over **141 surgeries in FY25**, expanded to Raipur hospital. - **Oncology**: - Radiation oncology launched at **Agartala** (only cancer care hospital in Tripura). - **CBCC (U.S.) partnership** for LINAC-based services in Agartala (11% revenue share). - Chemotherapy, oncology surgeries, and upcoming **liver transplants** in Raipur. - **Advanced Diagnostics**: 3 Tesla MRI, Dual Source CT, Cardiac Cath Lab across multiple facilities. - **Cardiology**: Strengthening Dum Dum with top specialist recruitment; full-fledged unit planned. --- ### **Strategic Growth & Expansion Plans** - **1,000-Bed Vision**: Targeting **1,000 beds within 2–3 years** (from 719 in Nov 2025), primarily via greenfield hospitals in Tier I and Tier II cities. - **Upcoming Expansion**: - **Jamshedpur, Jharkhand**: 150-bed hospital under MoU; investment of ₹65–74 crore; expected operational by **Q3 FY27**. - **Ranchi (Jharkhand)**: Lease signed; development underway. - Future targets: **Varanasi, Cuttack, Assam, Odisha**. - **Hospital Model**: Right-sized (150–200 beds), asset-light (e.g., Raipur on lease), low per-bed capex (~₹3.6M per bed). --- ### **Technology & Digital Initiatives** - **Hospital Management Information System (HMIS)**: Digital records, real-time reporting, WhatsApp/email delivery, appointment booking. - **Mobile App (ILS-MyHealth)**: Scheduled Q4 FY24 launch; features include e-consultations, medical records access, and hospital info. - **Backend Custom App**: Streamlines internal operations and improves efficiency. --- ### **Accreditations & Reputation** - All five hospitals are **NABH and NABL accredited**. - Strong community presence as **trusted "neighbourhood hospitals"** in high-density urban micro-markets. - Positioned near major transport hubs (rail, airport) for enhanced accessibility. - Clinical research participation (e.g., BEMAKI trial on acute kidney injury at Dum Dum).